Anis Barmada

Shedding light on the drivers of rare myocarditis after mRNA SARS-CoV-2 vaccination. An important step towards fully realizing the tremendous potential of mRNA vaccines. Our latest paper published today in @SciImmunology. A summary: (1/11) science.org/doi/10.1126/sc…

📣 Paul & Daisy Soros Fellowships for New Americans is in 3rd place and so close to joining the #Webbys Winners Circle. RT + VOTE: vote.webbyawards.com/PublicVoting#/…

Thankful for @PDSoros's continued support and excited for what’s next @Forbes, stay tuned!

The Yale Journal of Biology and Medicine is the 130th #GAJET (Good Academic Journal in Ethical Terms) CONGRATULATIONS @theYJBM & thank u @YaleMed 4 sponsoring & publishing #DiamondOpenAccess gajetlist.org/the-yale-journ… #OpenAccess #PublicationEthics #Ethics @COPE @ICMJE

Mark your calendars for an upcoming colloquium with Dr. Akiko Iwasaki

Doing good science is 90% finding a science buddy to constantly talk to about the project.

So thrilled to see people happy with @GlassHealthHQ and you are so right…so much effort has gone into this by the most passionate and intelligent group of physicians and engineers I’ve ever met!

@HendersonShalom CONGRATULATIONS @HendersonShalom!! So happy for you!

Late tweet but I did a little photoshoot with two of the longest labours I’ve experienced #PhDSubmitted

Artificial intelligence is already transforming the way we practice medicine. In @GlassHealthHQ's Future of Medicine essay contest and scholarship, medical students are challenged to envision how technology can be leveraged to change healthcare for the better. #MedX #MedTwitter

Very pleased to share our comprehensive review on monoclonal antibodies against circumsporozoite protein and how this emerging tool might aid global efforts to control malaria, published today in Nature Immunology! @AzzaIdris_1, we did it! :) nature.com/articles/s4159…

We’re thrilled to launch Modes on our Glass AI CDS platform! Our AI responses are now tailored to specific specialties, starting with Internal Medicine and Emergency Medicine. Enhance your differential diagnoses and plans with specialty-aligned outputs at glass.health.

Today, we're excited to launch IM & EM Modes for our AI-generated DDx & A&P drafts.🥳 With AI responses tailored by specialty, Glass is a more useful clinical assistant than ever before. Try Modes for yourself today at glass.health!🎊 #MedX #MedTwitter 🩺

Something that validates the Yale system @YaleMed. Giving learners more autonomy makes them more engaged with their learning than using punitive/controlling devices like mandatory attendance counting toward grades. science.org/doi/10.1126/sc…

We co-published b2b papers describing >400 human monoclonal antibodies against the malaria blood-stage antigen RH5! These data will guide testing of current RH5-based vaccines in Africa and improvement of future vaccine candidates. sciencedirect.com/science/articl… sciencedirect.com/science/articl…

Celebrating Great Immigrants, Great Americans Like Jensen Huang, @ylecun, @ashishkjha, @Ilibagiza, Viviana Gradinaru, and so many others who've made vital contributions to the US and beyond @CarnegieCorp #HappyFourth

Immigrants and children of immigrants give back to our country in profound ways, bringing innovation and creativity. Our Fellowship celebrates this profound gift. If you're a New American in/or pursuing grad school in 2025-2026, apply by 10/31! profellow.com/announcements/…

The YJBM June 2024 issue on Chronic Disease is available on PubMed Central, read here for free: ncbi.nlm.nih.gov/pmc/issues/465… Editors-in-Chief: Anis Barmada, Charlotte Godfrey, Samantha Seneviratne, and Morgan Vanderwall. Deputy Editors: Noah Yann Lee and Bassel Shanab.

new @ScienceMagazine framework to improve cancer early detection: two injectable priming agents (nanoparticles & engineered antibodies) temporarily slow down the clearance of circulating tumor DNA from the body, allowing for higher detection sensitivity science.org/doi/10.1126/sc…

An important thread by 2021 #PDSoros Fellow and recent @mit_hst/@harvardmed graduate @JamesADiao:

The future is really here 😳

⚡️🔬📣 Excited to share our new @Nature article building and evaluating PathChat, a multimodal generative AI copilot and chatbot for human pathology. Article: nature.com/articles/s4158… Open Access Link: rdcu.be/dKC0r We leverage our previous success in building foundation models for computational pathology such as UNI / CONCH and combine it with the advancements of large vision language models and generative AI to enable PathChat to answer diverse pathology-related queries. We assessed PathChat using both multiple choice diagnostic questions and open-ended questions. Congratulations to @MYLu97 @chenbowen118 @DFKW_MD @richardjchen and everyone else who contributed to this work. Also see blog post from @MYLu97 about this work: linkedin.com/pulse/towards-… , also teasing the development and preview of PathChat 2, a successor to PathChat 1 bringing new capabilities and substantially improved performance to the state-of-the-art.